NUR 514 Topic 5 Assignment; CLC - When Patient Advocacy Meets Policy; Lobbying for Health Care Change Presentation, Latest 2021/2022 Complete Guide, A Graded.

CLC - WHEN PATIENT ADVOCACY MEETS POLICY: LOBBYING FOR HEALTH CARE CHANGE PRESENTATION STUDENT’S NAME INSTITUTION INTRODUCTION: PRESCRIPTION DRUGS PRICING • In the United States, spending on prescription drugs reached approximately $457 billion as of 2015, which accounts for 17% of the total cost for personal healthcare services (Cohen, 2016). • Insurance companies, on the other hand, are shifting this high prescription drug costs to consumers in different forms such as high insurance premiums, co-payments, and deductibles. • Consequently, the high cost has made it hard for most consumers to acquire essential drugs. • Nearly 1 out of 10 Americans adults reported not taking their medication last year as a way of saving money. • The out of control drug prices has posed a great challenge to every America, especially in Texas. This study source was downloaded by from CourseH on 09-23-2021 02:34:49 GMT -05:00 PRESCRIPTION DRUGS PRICING IN RELATION TO NURSING PRACTICE • The main objective of an advanced registered nurse leader is focused on enhancing wellness and preventive healthcare as per the consumer demands (Patel, & Rushefsky, 2014). • The increasing cost of prescription drugs has however crippled this objective as nurses are unable to enhance a cost-effective, high-quality care provision. • For instance, medications, especially for the treatment and prevention of chronic illness have a substantial effect in reducing morbidity and mortality rates. • Medication has great value only if the consumer has access to it. Failure to access essential drugs put no value to medication in the first place, hence undermining the patient’s health and the entire care process. This study source was downloaded by from CourseH on 09-23-2021 02:34:49 GMT -05:00 IMPLICATIONS IF LOBBYING EFFORTS DO NOT SUCCEED To the consumer: • High rates of bankruptcies • Abandoned or compromised treatments • Untreated infections that might render the patient prone to chronic illnesses like heart attack • Poor quality of life • Increased morbidity and mortality rates This study source was downloaded by from CourseH on 09-23-2021 02:34:49 GMT -05:00 IMPLICATIONS IF LOBBYING EFFORTS DO NOT SUCCEED To the healthcare system: • Shortage of drugs in healthcare settings • Increased number of counterfeit drugs • Lack of transparency • Reduced quality of health provided This study source was downloaded by from CourseH on 09-23-2021 02:34:49 GMT -05:00 REFERENCES • Patel, K., & Rushefsky, M. E. (2014). Healthcare politics and policy in America. Armonk, New York: M.E. Sharpe. • Parker-Lue, S., Santoro, M., & Koski, G. (January 01, 2015). The Ethics and Economics of Pharmaceutical Pricing. Annual Review of Pharmacology and Toxicology, 55, 191- 206. • Ghosh, A., Simon, K., & Sommers, B. D. (January 01, 2019). The Effect of Health Insurance on Prescription Drug Use Among Low-Income Adults: Evidence from Recent Medicaid Expansions. Journal of Health Economics, 63, 64-80. • Cohen, S. S. (January 01, 2016). Soaring Prescription Drug Prices. Policy, Politics & Nursing Practice, 17, 3, 115-117.